DIVIDEND ANNOUNCEMENT: Amgen Inc (NASDAQ:AMGN) on 08/01/2023 declared a dividend of $2.1300 per share

Amgen Inc (NASDAQ:AMGN) on 08/01/2023 declared a dividend of $ 2.1300 per share payable on September 08, 2023 to shareholders of record as of August 18, 2023.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 3.6386933327% and has increased its dividends for 11 successive years.

Amgen Inc's market cap is $ 125,112,667,050 and has a PE ratio of 15.92. The stock price closed yesterday at $ 234.15 and has a 52 week low/high of $ 211.71 and $ 296.67.

Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

For more information on Amgen Inc click here.